Ching‐Hung Lin
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer Risks and Factors
Papers in
- Oncology 38
- Cancer Risks and Factors 11
- Cancer Treatment and Pharmacology 10
- HER2/EGFR in Cancer Research 6
-
- Breast Cancer Treatment Studies 19
- Co-authors
- Yen‐Shen Lu (73 shared papers)Ann‐Lii Cheng (45 shared papers)Chiun-Sheng Huang (38 shared papers)Kuan‐Ting Kuo (15 shared papers)Wen‐Hung Kuo (18 shared papers)Ching‐Hua Kuo (12 shared papers)Sung‐Hsin Kuo (10 shared papers)I‐Chun Chen (17 shared papers)
- Journals
- Breast Cancer Research and Treatment (7 papers)The Oncologist (6 papers)Scientific Reports (5 papers)BMC Cancer (4 papers)The Breast (4 papers)
- Partner nations
- TaiwanUnited StatesSingapore
In The Last Decade
Ching‐Hung Lin
114 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 126
- Cancer Research 583
- Oncology 868
- Genetics 189
- Otorhinolaryngology 69
- Pathology and Forensic Medicine 281
Countries citing papers authored by Ching‐Hung Lin
This map shows the geographic impact of Ching‐Hung Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Hung Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Hung Lin more than expected).
Fields of papers citing papers by Ching‐Hung Lin
This network shows the impact of papers produced by Ching‐Hung Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Hung Lin. The network helps show where Ching‐Hung Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ching‐Hung Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 128 | |
| 2 | 2010 | 107 | |
| 3 | 2009 | 107 | |
| 4 | 2006 | 105 | |
| 5 | 2013 | 99 | |
| 6 | 2022 | 99 | |
| 7 | 2011 | 98 | |
| 8 | 2019 | 96 | |
| 9 | 2020 | 81 | |
| 10 | 2016 | 78 | |
| 11 | 2016 | 75 | |
| 12 | 2008 | 72 | |
| 13 | 2015 | 71 | |
| 14 | 2010 | 62 | |
| 15 | 2018 | 61 | |
| 16 | 2015 | 60 | |
| 17 | 2008 | 59 | |
| 18 | 2006 | 56 | |
| 19 | 2011 | 51 | |
| 20 | 2011 | 51 |
About Ching‐Hung Lin
Ching‐Hung Lin is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Molecular Biology, having authored 117 papers that have together received 3.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (19 papers), Brain Metastases and Treatment (12 papers), Cancer Risks and Factors (11 papers), Cancer Treatment and Pharmacology (10 papers), Estrogen and related hormone effects (6 papers), HER2/EGFR in Cancer Research (6 papers), Advanced Breast Cancer Therapies (5 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Cancer Research (583 citations), Oncology (868 citations), Genetics (189 citations), Otorhinolaryngology (69 citations) and Pathology and Forensic Medicine (281 citations). Ching‐Hung Lin has collaborated with scholars based in Taiwan, United States and Singapore. Frequent co-authors include Yen‐Shen Lu, Ann‐Lii Cheng, Chiun-Sheng Huang, Kuan‐Ting Kuo, Wen‐Hung Kuo, Ching‐Hua Kuo, Sung‐Hsin Kuo, I‐Chun Chen, Huang‐Chun Lien and Tom Wei‐Wu Chen. Their work appears in journals such as Breast Cancer Research and Treatment, The Oncologist, Scientific Reports, BMC Cancer and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.